These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 17314195

  • 1. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C.
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [Abstract] [Full Text] [Related]

  • 2. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.
    Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG.
    Biol Psychiatry; 2005 Nov 15; 58(10):831-7. PubMed ID: 16018977
    [Abstract] [Full Text] [Related]

  • 3. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
    Bonaventure P, Dugovic C, Kramer M, De Boer P, Singh J, Wilson S, Bertelsen K, Di J, Shelton J, Aluisio L, Dvorak L, Fraser I, Lord B, Nepomuceno D, Ahnaou A, Drinkenburg W, Chai W, Dvorak C, Sands S, Carruthers N, Lovenberg TW.
    J Pharmacol Exp Ther; 2012 Aug 15; 342(2):429-40. PubMed ID: 22570363
    [Abstract] [Full Text] [Related]

  • 4. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A.
    Neuropharmacology; 2007 Apr 15; 52(5):1274-83. PubMed ID: 17320917
    [Abstract] [Full Text] [Related]

  • 5. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
    Sarkisyan G, Roberts AJ, Hedlund PB.
    Behav Brain Res; 2010 May 01; 209(1):99-108. PubMed ID: 20097233
    [Abstract] [Full Text] [Related]

  • 6. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
    Wesołowska A, Nikiforuk A, Stachowicz K.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):185-90. PubMed ID: 17097082
    [Abstract] [Full Text] [Related]

  • 7. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
    Monti JM, Jantos H.
    Behav Brain Res; 2006 Feb 28; 167(2):245-50. PubMed ID: 16290281
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA, Hughes ZA, Starr KR, Storey JD, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan JJ, Price GW.
    Neuropharmacology; 2006 Jun 28; 50(8):975-83. PubMed ID: 16581092
    [Abstract] [Full Text] [Related]

  • 10. Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT.
    Faure C, Mnie-Filali O, Scarna H, Debonnel G, Haddjeri N.
    Neurosci Lett; 2006 Aug 14; 404(1-2):122-6. PubMed ID: 16759802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
    Monti JM, Leopoldo M, Jantos H, Lagos P.
    Pharmacol Biochem Behav; 2012 Aug 14; 102(2):373-80. PubMed ID: 22659581
    [Abstract] [Full Text] [Related]

  • 13. Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors.
    Tokarski K, Zahorodna A, Bobula B, Grzegorzewska M, Pitra P, Hess G.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):60-6. PubMed ID: 16253236
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice.
    Günther L, Liebscher S, Jähkel M, Oehler J.
    Eur J Pharmacol; 2008 Sep 28; 593(1-3):49-61. PubMed ID: 18657534
    [Abstract] [Full Text] [Related]

  • 15. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J, Hyttel J, Overø KF.
    Pol J Pharmacol Pharm; 1984 Sep 28; 36(2-3):221-30. PubMed ID: 6591152
    [Abstract] [Full Text] [Related]

  • 16. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E.
    Neuropharmacology; 2006 Sep 28; 51(3):578-86. PubMed ID: 16828124
    [Abstract] [Full Text] [Related]

  • 17. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
    Shelton J, Bonaventure P, Li X, Yun S, Lovenberg T, Dugovic C.
    Neuropharmacology; 2009 Feb 28; 56(2):448-54. PubMed ID: 18948124
    [Abstract] [Full Text] [Related]

  • 18. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R, Boggs JD, Miller KL, Bonaventure P, Atack JR.
    Behav Pharmacol; 2008 Mar 28; 19(2):153-9. PubMed ID: 18332680
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors.
    Zhu H, Huang Q, Xu H, Niu L, Zhou JN.
    Behav Brain Res; 2009 Jan 23; 196(2):200-6. PubMed ID: 18817816
    [Abstract] [Full Text] [Related]

  • 20. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Jan 23; 54(6):615-23. PubMed ID: 12866716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.